Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer.

Karam SD, Horne ZD, Hong RL, McRae D, Duhamel D, Nasr NM.

Radiat Oncol. 2013 Jul 10;8:179. doi: 10.1186/1748-717X-8-179.

2.

Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.

Parks J, Kloecker G, Woo S, Dunlap NE.

Am J Clin Oncol. 2016 Apr;39(2):147-53. doi: 10.1097/COC.0000000000000039.

PMID:
24457534
3.

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.

Kelley KD, Benninghoff DL, Stein JS, Li JZ, Byrnes RT, Potters L, Knisely JP, Zinkin HD.

Radiat Oncol. 2015 May 28;10:120. doi: 10.1186/s13014-015-0423-7.

4.

Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.

Feddock J, Arnold SM, Shelton BJ, Sinha P, Conrad G, Chen L, Rinehart J, McGarry RC.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1325-31. doi: 10.1016/j.ijrobp.2012.11.011.

PMID:
23265574
5.

Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.

Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Rumeileh IA, Trovo MG.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1114-9. doi: 10.1016/j.ijrobp.2014.01.012.

PMID:
24661664
6.

Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.

Haidar YM, Rahn DA 3rd, Nath S, Song W, Bazhenova L, Makani S, Fuster MM, Sandhu AP.

Ther Adv Respir Dis. 2014 Feb;8(1):3-12. doi: 10.1177/1753465813512545.

PMID:
24334338
7.

Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.

Ricardi U, Frezza G, Filippi AR, Badellino S, Levis M, Navarria P, Salvi F, Marcenaro M, Trovò M, Guarneri A, Corvò R, Scorsetti M.

Lung Cancer. 2014 Jun;84(3):248-53. doi: 10.1016/j.lungcan.2014.02.015.

PMID:
24681279
8.

Gefitinib combined with stereotactic radiosurgery in previously treated patients with advanced non-small cell lung cancer.

Wang Z, Zhu XX, Wu XH, Li B, Shen TZ, Kong QT, Li J, Liu ZB, Jiang WR, Wang Y, Hou B.

Am J Clin Oncol. 2014 Apr;37(2):148-53. doi: 10.1097/COC.0b013e31826e071b.

PMID:
23211223
9.

Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC).

Lucas JT Jr, Kuremsky JG, Soike M, Hinson WW, Kearns WT, Hampton CJ, Blackstock AW, Urbanic J.

Lung Cancer. 2014 Jul;85(1):59-65. doi: 10.1016/j.lungcan.2014.04.003.

PMID:
24813936
10.

Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancer.

Hayashi S, Tanaka H, Kajiura Y, Ohno Y, Hoshi H.

Radiat Oncol. 2014 Jun 16;9:138. doi: 10.1186/1748-717X-9-138.

11.

Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?

Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8. doi: 10.1016/j.ijrobp.2009.07.1751.

PMID:
20638194
12.

Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.

Horne ZD, Clump DA, Vargo JA, Shah S, Beriwal S, Burton SA, Quinn AE, Schuchert MJ, Landreneau RJ, Christie NA, Luketich JD, Heron DE.

Radiat Oncol. 2014 Jan 30;9:41. doi: 10.1186/1748-717X-9-41.

13.

Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis.

Bahig H, Filion E, Vu T, Roberge D, Lambert L, Bouchard M, Lavoie C, Doucet R, Nadeau DB, Chalaoui J, Campeau MP.

Technol Cancer Res Treat. 2015 Dec;14(6):667-76. doi: 10.7785/tcrt.2012.500445.

PMID:
24988054
14.

Impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy.

Atallah S, Cho BC, Allibhai Z, Taremi M, Giuliani M, Le LW, Brade A, Sun A, Bezjak A, Hope AJ.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):532-8. doi: 10.1016/j.ijrobp.2014.03.003.

PMID:
24929163
15.

Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).

Dunlap NE, Larner JM, Read PW, Kozower BD, Lau CL, Sheng K, Jones DR.

J Thorac Cardiovasc Surg. 2010 Sep;140(3):583-9. doi: 10.1016/j.jtcvs.2010.01.046.

16.

Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients.

Dworzecki T, Idasiak A, Syguła D, Dworzecka U, Suwiński R.

Neoplasma. 2012;59(1):114-20.

PMID:
22103905
17.

Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.

Woody NM, Stephans KL, Marwaha G, Djemil T, Videtic GM.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):325-31. doi: 10.1016/j.ijrobp.2015.01.045.

PMID:
25841625
18.

Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.

Salazar OM, Sandhu TS, Lattin PB, Chang JH, Lee CK, Groshko GA, Lattin CJ.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):707-15. doi: 10.1016/j.ijrobp.2008.01.054.

PMID:
18455322
19.

Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer.

Collins BT, Vahdat S, Erickson K, Collins SP, Suy S, Yu X, Zhang Y, Subramaniam D, Reichner CA, Sarikaya I, Esposito G, Yousefi S, Jamis-Dow C, Banovac F, Anderson ED.

J Hematol Oncol. 2009 Jan 17;2:1. doi: 10.1186/1756-8722-2-1.

20.

[An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].

Guillerme F, Clavier JB, Schumacher C, Falcoz PE, Bourrhala K, Santelmo N, Hassler S, Schott R, Quoix E, Massard G, Noël G.

Cancer Radiother. 2013 Jul-Aug;17(4):272-81. doi: 10.1016/j.canrad.2013.01.021. French.

PMID:
23712043
Items per page

Supplemental Content

Support Center